🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalJapan GLP-1 access — navigating the Japanese healthcare system Page 2

Japan GLP-1 access — navigating the Japanese healthcare system

mark_tokyo Thu, Jun 4, 2026 at 1:04 AM 8 replies 277 viewsPage 2 of 2
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Jun 4, 2026 at 4:53 AM#6

The figures, for anyone assembling their own picture. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: Jun 4, 2026 at 8:53 AM
45 15wanda_boise, NurseAsh_DET, BenResearch_OR and 42 others
Reply Quote Save Share Report
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Jun 4, 2026 at 6:22 AM#7

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

Last edited: Jun 4, 2026 at 12:22 PM
44 14alex_tucson, kevin_tulsa, Dr.PainCLE and 41 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Jun 4, 2026 at 7:51 AM#8
PeptideSynthNJ said:
Worth stating the units and the reference range whenever you post a number here.

There is a second half to this that has not been said yet. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

43 13AttorneyGrant, DebRD_ATL, KristenIndy and 40 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Jun 4, 2026 at 9:20 AM#9

OP back with an update, since a thread like this is useless without one.

Resolved, and the thing that resolved it was the least interesting suggestion in the thread. Writing that down for the next person who wants the interesting answer.

Last edited: Jun 4, 2026 at 12:20 PM
42 12HPLC_Greg, LibrarianMeg, bri_stats and 39 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Jun 4, 2026 at 4:26 PM#10
Dr.PulmRoch said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

I would rather be corrected than agreed with, if it comes to it.

26 1Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 23 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register